AbbVie and Big Pharma Have Floundered. How That Could Change in 2024.
Goldman Sachs still sees headwinds for the sector next year, but AbbVie could be an outlier.
Source: marketwatch.com
Stay updated with breaking news from Street Notes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Goldman Sachs still sees headwinds for the sector next year, but AbbVie could be an outlier.
McDonald’s is opening the first restaurant from its new spinoff chain, CosMc’s. The fast-food chain wants to become a key player in the fast-casual coffee...
SpaceX’s success enabled the business models of space startups. Now that success is a threat.
Biotech deals are heating up as the year comes to an end, and analysts say the hot streak will likely continue in coming months. AbbVie and Roche Holding...
Summit Insight Group analyst Kinngai Chan upgraded Broadcom stock to Buy from Hold.